Corbus Pharmaceuticals Holdings Inc
NASDAQ:CRBP
Corbus Pharmaceuticals Holdings Inc
NASDAQ:CRBP
Price:
42.8 USD
3.13%
Market Closed
Updated:
Jun 1, 2024
Corbus Pharmaceuticals Holdings Inc
PP&E Gross
|
Corbus Pharmaceuticals Holdings Inc
PP&E Gross Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | PP&E Gross | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Corbus Pharmaceuticals Holdings Inc
NASDAQ:CRBP
|
PP&E Gross
$4m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
PP&E Gross
$5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Corbus Pharmaceuticals Holdings Inc's PP&E Gross?
PP&E Gross
4m
USD
4m
USD
Based on the financial report for Dec 31, 2023, Corbus Pharmaceuticals Holdings Inc's PP&E Gross amounts to 4m USD.
What is Corbus Pharmaceuticals Holdings Inc's PP&E Gross growth rate?
PP&E Gross CAGR 5Y
8%
8%
Over the last year, the PP&E Gross growth was -27%. The average annual PP&E Gross growth rates for Corbus Pharmaceuticals Holdings Inc have been -24% over the past three years , 8% over the past five years .
You don't have any saved screeners yet
